MedPath

Comparing the time required by intramuscular and intranasal forms of Midazolam in aborting seizure

Not Applicable
Completed
Conditions
Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
Registration Number
CTRI/2020/01/022749
Lead Sponsor
Government Medical College and Hospital Aurangabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
247
Inclusion Criteria

1. Children in age group of 6 months to 12 years with active seizures without I. V. access

2. Patients with written valid and informed consent obtained from their parents

Exclusion Criteria

1. Child who received emergency treatment for present seizures from elsewhere

2. Child with clinically significant psychiatric disorder

3. Children with upper respiratory tract infection and profuse nasal discharge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath